How New Research Findings Will Change Cannabis Genetics In The Future
Genetics
Cannabis is making its way into mainstream science at a rapid pace. In the past, it was officially claimed that cannabis had no medicinal potential and a massive risk of abuse. As a result, cannabis has been largely ignored as a potential drug for the past several decades. This is currently beginning to change. Today, cannabis is the darling of the medical world.
More money than ever is pouring into the scientific research of cannabis. More and more established pharmaceutical companies are interested in securing a part of the lucrative future market. Cannabis research is becoming easier and easier as laws around the world relax. The medical benefits of cannabis are increasingly recognized.
Some of the current research could have a profound impact on the types of cannabis seeds one will grow in the future and the types of effects they produce. It may be possible in the future to have your own endo-cannabinoid system mapped. The endo-cannabinoid system is the part of the body to which the ingested cannabinoid molecules bind and react. Who knows, one day there may be the perfect cannabis strain for your endocannabinoid system.
Genetics
Numerous pharmaceutical companies and research groups around the world are researching cannabis. Hundreds of millions of euros, if not billions of euros, are poured into cannabis research. Pharmaceutical companies fund their own extensive research. Little is disclosed about the research until a patent is applied for, the publication of scientific papers or the launch of a new product.
Patents are legal means to prevent others from copying your product. The possibility that someone will one day find a way to market a new strain of cannabis for their own financial gain and prevent someone else from tackling the same issue is something the cannabis community is rightly very concerned about.
A recently published research paper looks at the genetics of high-CBD and high-THC strains. People are trying to understand what, at the genetic level, causes cannabis to grow the way it is. While cannabis was illegal, studying how cannabis DNA controls growth has been difficult.
Today, the whole scientific world is looking at cannabis. On the one hand, this is a huge potential market for future drugs. On the other hand, pharmaceutical companies still have a long and very expensive road ahead of them.
Today, the whole scientific world is looking at cannabis. On the one hand, this is a huge potential market for future drugs. On the other hand, pharmaceutical companies still have a long and very expensive road ahead of them. Today, the whole scientific world is looking at cannabis. On the one hand, this is a huge potential market for future drugs. On the other hand, pharmaceutical companies still have a long and very expensive road ahead of them.
Cannabis Research and Big Pharma.
Genetics
In reality, it will take years for medical researchers to figure out the various benefits of each cannabinoid. Then it will take some time for clinical trials with potential drugs. There are several serious complications to cannabis research. Firstly, very little research has been done due to the ban. Second, the cannabinoids can enhance each other’s effects when used together (entourage effect). This could complicate research. Third, there is a very wide range of medical applications that need to be explored.
Big Pharma will do its best to dominate the medical cannabis market for years to come with well-tailored and expensive cannabis-based drugs. In the meantime, many medicinal users will simply grow their own cannabis from feminized seeds or autoflowering seeds and get good results. Growing your own cannabis seeds is still the cheapest way to make your own medicinal or recreational cannabis.
Medicinal uses of cannabis.
Genetics
Throughout history, many people have found cannabis to be very effective for certain medical conditions. MS users can relieve muscle stiffness with cannabis. AIDS patients use cannabis to improve appetite. Some cancer patients experience additional pain relief and well-being after consuming cannabis. For some people, cannabis reduces the nausea associated with chemotherapy. For others, it helps them get a good night’s sleep. Patients with Crohn’s disease report fewer symptoms.
People with treatment-resistant depression, PTSD, anxiety, and other conditions have also reported the beneficial medicinal effects of cannabis. Epilepsy patients, including children, have reported a truly remarkable reduction in seizures when consuming cannabis oil.
The list of areas with clear medical benefits is vast. These are unique prerequisites for a potential medicine that explain Big Pharma’s interest. Many smaller cannabinoids have received very little attention, making it difficult for modern researchers, whether from pharmaceutical companies, academia or the cannabis industry.
Genetics
Despite the hype, there are no genetically modified cannabis strains, at least not yet. The cost of genetically modified cannabis would amount to tens of millions of euros. There are some proposals that would cost over 100 million euros. This is partly due to the complexity and time involved.
After launching a GM (genetically modified) project, it often takes a decade or more before commercial revenue can be generated from a future product. Such a large research project would probably be too expensive for a single company. Especially since it would not be clear whether there were guaranteed successes.
One possible approach would be to increase the cannabinoid content or type. Or maybe increase growth speed or get bigger yields from monstrous plants. Perhaps one day a GM cannabis project will be launched, although it is sure to be extremely controversial and perhaps unpopular in the cannabis community. Most cannabis enthusiasts are uncomfortable with the thought of genetically engineering cannabis. Especially if it comes from a pharmaceutical company that is patenting their work and will commercialize it for profit.
Genetics
High quality seed banks like Dutch Passion are researching future cannabis strains that will be rich in some of the smaller cannabinoids. CBD-rich cannabis seeds have shown that this is possible. Selective breeding is underway that could allow future cannabis seed varieties to be high in CBG, THC-V or CBD-V for example.
These seeds will likely be available initially as feminized seeds and later perhaps as feminized autoflowering seeds. These could have interesting properties for medicinal users, as well as a slightly different psychoactive effect. You will continue to get the latest information on the Dutch Passion blog.
For More Updates Click Here